文献速递糖尿病

胰腺炎后糖尿病比2型糖尿病具有更高的胰腺癌风险:来自全国癌症登记处的数据

Postpancreatitis Diabetes Confers Higher Risk for Pancreatic Cancer Than Type 2 Diabetes: Results From a Nationwide Cancer Registry.
PubMed 文献 · Diabetes Care · 2020-07-02

该研究基于新西兰1998至2015年全国癌症登记处与出院及死亡数据的关联,纳入139,843人(735,541人年),比较2型糖尿病、单纯胰腺炎、2型糖尿病后胰腺炎及胰腺炎后糖尿病四组的胰腺癌发病率。以2型糖尿病为参照,胰腺炎后糖尿病(HR 6.94;95%CI 4.09-11.77)和2型糖尿病后胰腺炎(HR 5.35;95%CI 3.52-8.14)的胰腺癌风险显著更高。头对头比较中,胰腺炎后糖尿病较2型糖尿病后胰腺炎风险更高(HR 2.35;95%CI 1.12-4.93)。

要点

  • 胰腺炎后糖尿病患者胰腺癌比例为3.1%,2型糖尿病后胰腺炎为2.3%,单纯胰腺炎为2.0%,单纯2型糖尿病为0.6%。
  • 以2型糖尿病为参照,胰腺炎后糖尿病胰腺癌风险HR 6.94(95%CI 4.09-11.77),2型糖尿病后胰腺炎HR 5.35(95%CI 3.52-8.14)。
  • 头对头比较中,胰腺炎后糖尿病较2型糖尿病后胰腺炎胰腺癌风险更高(HR 2.35;95%CI 1.12-4.93)。

核心结论

  • 胰腺炎显著增加糖尿病患者发生胰腺癌的风险,其中胰腺炎后糖尿病风险最高。

研究设计与样本

  • 全国癌症登记处与1998至2015年新西兰出院及死亡数据关联,纳入139,843人(735,541人年),比较四组胰腺癌发病率,采用多因素Cox回归,以2型糖尿病为参照组。

主要发现

  • 共913人(0.7%)诊断为胰腺癌;胰腺炎后糖尿病、2型糖尿病后胰腺炎、单纯胰腺炎和单纯2型糖尿病的胰腺癌比例分别为3.1%、2.3%、2.0%和0.6%。
  • 以2型糖尿病为参照,胰腺炎后糖尿病(HR 6.94;95%CI 4.09-11.77)和2型糖尿病后胰腺炎(HR 5.35;95%CI 3.52-8.14)的胰腺癌风险显著更高。
  • 头对头比较中,胰腺炎后糖尿病较2型糖尿病后胰腺炎胰腺癌风险更高(HR 2.35;95%CI 1.12-4.93)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pancreatitis and diabetes are established risk factors for pancreatic cancer. However, to date, studies have investigated only the risk associated with either of them alone. The aim of this study was to investigate the effect of pancreatitis and diabetes combined, as well as their temporal relationship, on the risk of pancreatic cancer. RESEARCH DESIGN AND METHODS: Nationwide cancer registry was linked to hospital discharge and mortality data from 1998 to 2015 in New Zealand. Incidence of primary pancreatic cancer in the four study groups (type 2 diabetes [T2D] alone, pancreatitis alone, T2D followed by pancreatitis, and postpancreatitis diabetes mellitus [PPDM]) was identified. Multivariable Cox regression analyses were conducted, with T2D as the reference group. A head-to-head comparison between the T2D followed by pancreatitis and PPDM groups was also performed. RESULTS: Among 139,843 individuals (735,541 person-years), 913 (0.7%) were diagnosed with pancreatic cancer. The proportion of pancreatic cancer was 3.1%, 2.3%, 2.0%, and 0.6% in individuals with PPDM, T2D followed by pancreatitis, pancreatitis alone, and T2D alone, respectively. PPDM (hazard ratio [HR] 6.94; 95% CI 4.09-11.77) and T2D followed by pancreatitis (HR 5.35; 95% CI 3.52-8.14) were associated with significantly higher risks of pancreatic cancer compared with T2D alone. In the head-to-head comparison, PPDM was associated with a higher risk of pancreatic cancer compared with T2D followed by pancreatitis (HR 2.35; 95% CI 1.12-4.93). CONCLUSIONS: Pancreatitis significantly increases the risk of pancreatic cancer in individuals with diabetes. In particular, PPDM poses the highest risk for pancreatic cancer.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Cho J, Scragg R, Petrov MS, et al. Postpancreatitis Diabetes Confers Higher Risk for Pancreatic Cancer Than Type 2 Diabetes: Results From a Nationwide Cancer Registry. Diabetes Care. 2020. PMID: 32616613. doi:10.2337/dc20-0207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。